Jasmohan S Bajaj Selected Research

Hepatic Encephalopathy

4/2022	Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort.
1/2022	Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis.
1/2022	Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis.
1/2022	Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
1/2022	Pharmacokinetics/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes.
1/2022	Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
12/2021	Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access.
12/2021	Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial.
1/2021	Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
1/2021	Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jasmohan S Bajaj Research Topics

Disease

85	Fibrosis (Cirrhosis) 10/2022 - 09/2003
44	Hepatic Encephalopathy 04/2022 - 04/2005
24	End Stage Liver Disease 01/2022 - 07/2008
22	Inflammation (Inflammations) 06/2022 - 11/2012
18	Liver Diseases (Liver Disease) 06/2022 - 09/2003
18	Infections 01/2021 - 03/2007
14	Dysbiosis 12/2021 - 01/2015
8	Acute-On-Chronic Liver Failure 01/2022 - 11/2018
8	Endotoxemia 11/2018 - 01/2013
7	Acute Kidney Injury (Acute Renal Failure) 06/2022 - 12/2013
7	Non-alcoholic Fatty Liver Disease 01/2022 - 06/2016
7	Peritonitis 01/2021 - 05/2009
5	Cognitive Dysfunction 01/2022 - 01/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 01/2018
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 01/2015
4	Hyperammonemia 12/2016 - 06/2010
3	Ascites 01/2022 - 05/2009
3	Hepatitis C 01/2022 - 09/2003
3	Neuroinflammatory Diseases 01/2021 - 10/2016
3	Disease Progression 01/2021 - 01/2015
3	Neoplasms (Cancer) 01/2020 - 01/2012
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2018 - 06/2014
3	Shock 01/2018 - 01/2014
3	Hemorrhage 05/2009 - 09/2007
2	Urinary Tract Infections (Urinary Tract Infection) 12/2022 - 01/2021
2	Chronic Renal Insufficiency 06/2022 - 01/2021
2	Portal Hypertension 01/2022 - 01/2021
2	Fatty Liver 12/2021 - 06/2016
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2018
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2015
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2019 - 01/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 05/2005
2	Bacteremia 01/2018 - 01/2016
2	Hyponatremia 01/2018 - 10/2015
2	Edema (Dropsy) 01/2017 - 01/2016
2	Necrosis 12/2016 - 07/2008
2	Acute Liver Failure (Fulminant Hepatic Failure) 11/2014 - 10/2013
2	Wounds and Injuries (Trauma) 01/2014 - 04/2007
2	Brain Diseases (Brain Disorder) 10/2013 - 03/2011
2	Ulcer 08/2008 - 09/2007
1	Substance-Related Disorders (Drug Abuse) 10/2022

Drug/Important Bio-Agent (IBA)

27	Rifaximin (L 105)FDA Link 10/2022 - 02/2011
19	Bile Acids and Salts (Bile Acids)IBA 06/2022 - 05/2013
16	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 03/2007
16	Lactulose (Duphalac)FDA LinkGeneric 10/2022 - 01/2012
16	Proton Pump InhibitorsIBA 01/2022 - 05/2009
14	AmmoniaIBA 01/2022 - 07/2008
8	CytokinesIBA 01/2022 - 02/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
6	AlbuminsIBA 01/2022 - 12/2012
6	CreatinineIBA 01/2022 - 12/2013
6	16S Ribosomal RNAIBA 01/2022 - 01/2019
5	SodiumIBA 12/2021 - 12/2017
4	Opioid Analgesics (Opioids)IBA 10/2022 - 10/2012
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 11/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2011
3	Interleukin-6 (Interleukin 6)IBA 12/2019 - 09/2012
3	Serum AlbuminIBA 01/2019 - 12/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2008
3	GlutaminaseIBA 12/2016 - 08/2016
3	Glutamine (L-Glutamine)FDA Link 10/2016 - 01/2016
3	InterleukinsIBA 10/2015 - 07/2008
2	BenzodiazepinesIBA 10/2022 - 01/2021
2	Vancomycin FDA LinkGeneric 06/2022 - 01/2021
2	ornithine phenylacetateIBA 01/2022 - 12/2021
2	polyethylene glycol alkylphenyl ether (OP 10)IBA 01/2022 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	Capsules (Microcapsules)IBA 01/2021 - 09/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2015
2	EnzymesIBA 01/2021 - 01/2014
2	LipidsIBA 11/2020 - 01/2020
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 01/2019
2	Cytidine Triphosphate (CTP)IBA 01/2020 - 04/2005
2	lipopolysaccharide-binding proteinIBA 12/2019 - 11/2018
2	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
2	HistatinsIBA 11/2018 - 10/2015
2	Muramidase (Lysozyme)IBA 11/2018 - 10/2015
2	EndotoxinsIBA 11/2018 - 09/2012
2	Pharmaceutical PreparationsIBA 06/2018 - 05/2005
2	RNA (Ribonucleic Acid)IBA 01/2018 - 09/2003
2	Omeprazole (Prilosec)FDA LinkGeneric 01/2018 - 11/2014
2	Amino Acids FDA Link 11/2017 - 08/2016
2	Ethanol (Ethyl Alcohol)IBA 10/2017 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2012 - 07/2008
1	TabletsIBA 06/2022

Therapy/Procedure

29	Therapeutics 10/2022 - 09/2003
17	Liver Transplantation 01/2022 - 07/2015
12	Fecal Microbiota Transplantation 01/2021 - 09/2015
4	Transplantation 01/2022 - 07/2015
4	Length of Stay 01/2021 - 07/2008
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 09/2015
3	Artificial Respiration (Mechanical Ventilation) 09/2021 - 01/2014
3	Antibiotic Prophylaxis 01/2019 - 05/2009
2	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 09/2015
2	Enema (Enemas) 01/2021 - 01/2021
2	Critical Care (Surgical Intensive Care) 01/2019 - 01/2018
2	Ligation 01/2018 - 08/2008
2	Cognitive Training 01/2017 - 02/2012
1	Eye Protective Devices (Goggles) 10/2022